Last updated: November 14, 2024
Sponsor: Insel Gruppe AG, University Hospital Bern
Overall Status: Active - Recruiting
Phase
N/A
Condition
Allergy
Eczema (Atopic Dermatitis - Pediatric)
Scalp Disorders
Treatment
Patch test application
Clinical Study ID
NCT03024671
KEK-BE 2016-01686
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Men and women older than 18 years old
Persons undergoing a diagnostic patch test for reason of a skin disease
Signed written informed consent
Exclusion
Exclusion Criteria:
Acute skin inflammation and eczema on the back
Systemic corticosteroid and immunosuppressive therapy as well as UV exposure of theback within the last 4 weeks
Topical corticosteroids used on the back within the last two weeks
Study Design
Total Participants: 180
Treatment Group(s): 1
Primary Treatment: Patch test application
Phase:
Study Start date:
February 10, 2017
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Inselspital Bern
Bern,
SwitzerlandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.